BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31858856)

  • 1. The potential of fecal microbiota transplantation in systemic sclerosis.
    Hoffmann-Vold AM; Fretheim H; Didriksen H; Molberg Ø
    Expert Rev Clin Immunol; 2020 Feb; 16(2):117-118. PubMed ID: 31858856
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple sclerosis and faecal microbiome transplantation: are you going to eat that?
    Wing AC; Kremenchutzky M
    Benef Microbes; 2019 Feb; 10(1):27-32. PubMed ID: 30525949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intestinal immune response is regulated by gut microbe].
    Tanemoto S; Sujino T; Kanai T
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(6):408-415. PubMed ID: 29367525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysbiosis and Gut Microbiota Modulation in Systemic Sclerosis.
    Lemos MPC; Zucoloto TG; Oliveira MC; de Oliveira GLV
    J Clin Rheumatol; 2022 Mar; 28(2):e568-e573. PubMed ID: 34030162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
    Raftery AL; Tsantikos E; Harris NL; Hibbs ML
    Front Immunol; 2020; 11():2144. PubMed ID: 33042125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment.
    Guo XY; Liu XJ; Hao JY
    J Dig Dis; 2020 Mar; 21(3):147-159. PubMed ID: 32040250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The microbiome in autoimmune diseases.
    De Luca F; Shoenfeld Y
    Clin Exp Immunol; 2019 Jan; 195(1):74-85. PubMed ID: 29920643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases.
    Mishima Y; Sartor RB
    J Gastroenterol; 2020 Jan; 55(1):4-14. PubMed ID: 31482438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases.
    Chen B; Sun L; Zhang X
    J Autoimmun; 2017 Sep; 83():31-42. PubMed ID: 28342734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should fecal microbial transplantation be used in the ICU?
    McClave SA; Patel J; Bhutiani N
    Curr Opin Crit Care; 2018 Apr; 24(2):105-111. PubMed ID: 29432297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplanting Fecal Virus-Like Particles Reduces High-Fat Diet-Induced Small Intestinal Bacterial Overgrowth in Mice.
    Lin DM; Koskella B; Ritz NL; Lin D; Carroll-Portillo A; Lin HC
    Front Cell Infect Microbiol; 2019; 9():348. PubMed ID: 31750259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal Microbiota Transplantation in Dogs.
    Chaitman J; Gaschen F
    Vet Clin North Am Small Anim Pract; 2021 Jan; 51(1):219-233. PubMed ID: 33131919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthy Donor Fecal Microbiota Transplantation in Steroid-Ineligible Severe Alcoholic Hepatitis: A Pilot Study.
    Philips CA; Pande A; Shasthry SM; Jamwal KD; Khillan V; Chandel SS; Kumar G; Sharma MK; Maiwall R; Jindal A; Choudhary A; Hussain MS; Sharma S; Sarin SK
    Clin Gastroenterol Hepatol; 2017 Apr; 15(4):600-602. PubMed ID: 27816755
    [No Abstract]   [Full Text] [Related]  

  • 15. Limited engraftment of donor microbiome via one-time fecal microbial transplantation in treated HIV-infected individuals.
    Vujkovic-Cvijin I; Rutishauser RL; Pao M; Hunt PW; Lynch SV; McCune JM; Somsouk M
    Gut Microbes; 2017 Sep; 8(5):440-450. PubMed ID: 28541799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal Microbiota Transplantation for the Critically Ill Patient.
    Limketkai BN; Hendler S; Ting PS; Parian AM
    Nutr Clin Pract; 2019 Feb; 34(1):73-79. PubMed ID: 30561131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.
    Mizuno S; Masaoka T; Naganuma M; Kishimoto T; Kitazawa M; Kurokawa S; Nakashima M; Takeshita K; Suda W; Mimura M; Hattori M; Kanai T
    Digestion; 2017; 96(1):29-38. PubMed ID: 28628918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal microbiota transplantation in the treatment of intestinal steroid-resistant graft-versus-host disease: two case reports and a review of the literature.
    Biernat MM; Urbaniak-Kujda D; Dybko J; Kapelko-Słowik K; Prajs I; Wróbel T
    J Int Med Res; 2020 Jun; 48(6):300060520925693. PubMed ID: 32527171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial.
    Fretheim H; Chung BK; Didriksen H; Bækkevold ES; Midtvedt Ø; Brunborg C; Holm K; Valeur J; Tennøe AH; Garen T; Midtvedt T; Trøseid M; Zarè H; Lund MB; Hov JR; Lundin KEA; Molberg Ø; Hoffmann-Vold AM
    PLoS One; 2020; 15(5):e0232739. PubMed ID: 32437393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered Gut Microbiota in HIV Infection: Future Perspective of Fecal Microbiota Transplantation Therapy.
    Kang Y; Cai Y
    AIDS Res Hum Retroviruses; 2019 Mar; 35(3):229-235. PubMed ID: 29877092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.